Two steroid-free immunosuppressive regimens (basiliximab/tacrolimus and tacrolimus/MMF) in comparison to tacrolimus/MMF/steroid therapy after renal transplantation

被引:0
|
作者
Kramer, BK
Klinger, M
Salmela, K
Wlodarczyk, Z
Tyden, G
Vitko, S
机构
[1] Univ Regensburg, D-8400 Regensburg, Germany
[2] Univ Wroclaw, PL-50138 Wroclaw, Poland
[3] Univ Helsinki, FIN-00014 Helsinki, Finland
[4] Poznan Hosp, Poznan, Poland
[5] Univ Stockholm, S-10691 Stockholm, Sweden
[6] Prague Agr Univ, Prague, Czech Republic
关键词
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:9A / 9A
页数:1
相关论文
共 50 条
  • [41] RELATIONSHIP OF TACROLIMUS EXPOSURE AND MMF (CellCept®) DOSE WITH RENAL FUNCTION AT ONE YEAR AFTER RENAL TRANSPLANTATION
    Ekberg, Henrik
    van Gelder, Teun
    Kaplan, Bruce
    Bernasconi, Corrado
    TRANSPLANT INTERNATIONAL, 2009, 22 : 7 - 7
  • [42] SAFETY AND EFFICACY OF STEROID-FREE IMMUNOSUPPRESSION USING BASILIXIMAB INDUCTION, TACROLIMUS AND ENTERIC COATED MYCOPHENOLATE SODIUM IN ADULT LIVER TRANSPLANTATION
    Ramirez, Carlo B.
    Doria, Cataldo
    Frank, Adam M.
    Navarro, Victor
    Herrine, Steven
    Rossi, Simona
    Chaballa, Mark
    Vaccino, Silvia
    Kang, Yoogoo
    Marino, Ignazio R.
    LIVER TRANSPLANTATION, 2008, 14 (07) : S109 - S109
  • [43] Improvement of HbA1C after Withdrawal of Sirolimus in a Steroid-Free Tacrolimus/Sirolimus Immunosuppressive Regimen.
    Gelens, M. A. C. J.
    Christiaans, M. H. L.
    Van Hooff, J. P.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2010, 10 : 514 - 514
  • [44] A comparison of two methods of tacrolimus based immunosuppression with or without MMF for early steroid withdrawal in children after liver transplantation. Results of one year follow up
    Teisseyre, Joanna
    Kalicinski, Piotr
    Markiewicz-Kijewska, Malgorzata
    Szymczak, Marek
    Ismail, Hor
    Nachulewicz, Pawel
    Drewniak, Tomasz
    Teisseyre, Mikolaj
    Kluge, Przemyslaw
    TRANSPLANT INTERNATIONAL, 2007, 20 : 31 - 32
  • [45] A randomized, multicenter comparison of tacrolimus and cyclosporine immunosuppressive regimens in cardiac transplantation: Decreased hyperlipidemia and hypertension with tacrolimus
    Taylor, DO
    Barr, ML
    Radovancevic, B
    Renlund, DG
    Mentzer, RM
    Smart, FW
    Tolman, DE
    Frazier, OH
    Young, JB
    VanVeldhuisen, P
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 1999, 18 (04): : 336 - 345
  • [46] A novel management strategy of steroid-free immunosuppression after liver transplantation:: Efficacy and safety of tacrolimus and mycophenolate mofetil
    Ringe, B
    Braun, F
    Schütz, E
    Füzesi, L
    Lorf, T
    Canelo, R
    Oellerich, M
    Ramadori, G
    TRANSPLANTATION, 2001, 71 (04) : 508 - 515
  • [47] Early steroid withdrawal in renal transplantation with tacrolimus dual therapy: A pilot study
    Boots, JMM
    Christiaans, MHI
    van Duijnhoven, EM
    van Suylen, RJ
    van Hooff, JP
    TRANSPLANTATION PROCEEDINGS, 2002, 34 (05) : 1698 - 1699
  • [48] Early steroid withdrawal in renal transplantation with tacrolimus dual therapy: A pilot study
    Boots, JMM
    Christiaans, MHL
    van Duijnhoven, EM
    van Suylen, RJ
    van Hooff, JP
    TRANSPLANTATION, 2002, 74 (12) : 1703 - 1709
  • [49] POPULATION PHARMACOKINETICS OF IMMEDIATE-RELEASE TACROLIMUS IN STEROID-FREE ADULT RENAL TRANSPLANT RECIPIENTS
    Rong, Yan
    Mayo, Patrick
    Ensom, Mary H. H.
    Kiang, Tony K. L.
    DRUG METABOLISM AND PHARMACOKINETICS, 2019, 34 (01) : S66 - S66
  • [50] Potential association between mycophenolate, but not tacrolimus, exposure and neutropenia in steroid-free renal transplant recipients
    Kiang, Tony K. L.
    Partovi, Nilufar
    Hussaini, Trana
    Shapiro, Rebecca Jean
    Ensom, Mary H. H.
    PHARMACOTHERAPY, 2013, 33 (10): : E239 - E239